Shares of SenesTech Inc (NASDAQ:SNES) traded up 12.2% during mid-day trading on Monday . The stock traded as high as $0.97 and last traded at $0.83. 1,609,800 shares traded hands during trading, an increase of 348% from the average session volume of 359,067 shares. The stock had previously closed at $0.74.

Several analysts recently issued reports on the company. Zacks Investment Research downgraded SenesTech from a “hold” rating to a “sell” rating in a research note on Tuesday, October 3rd. Craig Hallum set a $3.00 target price on SenesTech and gave the company a “buy” rating in a research note on Wednesday, November 22nd. Finally, Roth Capital decreased their target price on SenesTech from $3.75 to $14.00 and set a “buy” rating on the stock in a research note on Thursday, December 28th.

The company has a market cap of $13.09 and a P/E ratio of -0.62. The company has a current ratio of 2.94, a quick ratio of 2.67 and a debt-to-equity ratio of 0.17.

SenesTech (NASDAQ:SNES) last issued its earnings results on Wednesday, November 8th. The company reported ($0.28) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.31) by $0.03. The company had revenue of $0.02 million for the quarter, compared to the consensus estimate of $0.25 million. SenesTech had a negative return on equity of 190.41% and a negative net margin of 14,473.40%. sell-side analysts forecast that SenesTech Inc will post -1.16 EPS for the current year.

A number of large investors have recently added to or reduced their stakes in the business. Gilder Gagnon Howe & Co. LLC increased its stake in SenesTech by 3.0% in the 3rd quarter. Gilder Gagnon Howe & Co. LLC now owns 1,078,499 shares of the company’s stock worth $1,995,000 after acquiring an additional 31,330 shares during the last quarter. Skylands Capital LLC increased its stake in SenesTech by 139.8% in the 3rd quarter. Skylands Capital LLC now owns 87,483 shares of the company’s stock worth $162,000 after acquiring an additional 51,000 shares during the last quarter. Prudential PLC increased its stake in SenesTech by 49.3% in the 2nd quarter. Prudential PLC now owns 447,971 shares of the company’s stock worth $2,661,000 after acquiring an additional 147,971 shares during the last quarter. Finally, TCI Wealth Advisors Inc. bought a new stake in SenesTech in the 3rd quarter worth approximately $748,000. 14.44% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: This piece of content was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark laws. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2018/01/15/senestech-snes-trading-12-2-higher.html.

About SenesTech

SenesTech, Inc is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility control. It offers ContraPest, a fertility control product candidate. ContraPest’s technology and approach targets the reproductive capabilities of both sexes.

Receive News & Stock Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related stocks with our FREE daily email newsletter.